Clinical evaluation of insulin resistance and β-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus

Clinical Rheumatology

Volumn 23, Issue 5, 2004, Pages 416-420

  Tso, Tim K ^a   Huang, Hui Yu ^a   Chang, Chen Kang ^b   Liao, Ying Ju ^a   Huang, Wen Nan ^c  

^a SHIH CHIEN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

cell function; Homeostasis model assessment; Insulin resistance; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; DOUBLE STRANDED DNA; GLUCOSE; INSULIN;

ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; PANCREAS ISLET BETA CELL; PATIENT CODING; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; DNA; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, STATISTICAL; SEVERITY OF ILLNESS INDEX;

EID: 6344292048     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0908-5     Document Type: Article

References (26)

1. Moller DE, Flier JS (1991) Insulin resistance: mechanisms, syndromes, and implications. N Engl J Med 325:938-948
2. Flier JS, Kahn CR, Roth J (1979) Receptors, antireceptor antibodies and mechanisms of insulin resistance. N Engl J Med 300:413-419
3. Accili D, Barbetti F, Cama A et al. (1992) Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans. J Invest Dermatol 98:77S-81S
4. Kahn CR, Flier JS, Bar RS et al. (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med 294:739-745
5. Moller DE, Flier JS (1988) Detection of an alteration in the insulin-receptor gene in a patients with insulin resistance, acanthosis nigricans, and polycystic ovary syndrome (type A insulin resistance). N Engl J Med 319:1526-1529
6. Steinberg AD, Klinman DM (1988) Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 14:25-41
7. Magsino CH, Spencer J (1999) Insulin receptor antibodies and insulin resistance. South Med J 92:717-719
8. Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW (1998) Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report. Diabetes Care 21:1217-1220
9. Yamasaki H, Yamaguchi Y, Fujita N et al. (2000) Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Acta Diabetol 37:189-196
10. Baird JS, Johnson JL, Elliott-Mills D, Opas LM (1997) Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody. Lupus 6:275-278
11. Gehi A, Webb A, Nolte M, Davis J (2003) Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil. Arthritis Rheum 48:1067-1070
12. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P (2002) Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore) 81:87-100
13. Tardella L, Rossetti L, De Pirro R et al. (1983) Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycemia. J Clin Lab Immunol 12:159-165
14. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI (2002) Insulin resistance and risk for stroke. Neurology 59:809-815
15. Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087-1092
16. Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
17. Chang DM, Lan JL, Lin HY, Luo SF (2002) Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus. Arthritis Rheum 46: 2924-2927
18. Bombardier C, Gladman DD, Urowitz MB et al. (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630-640
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
20. Anderson RL, Hamman RF, Savage PJ et al. (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests: the Insulin Resistance Atherosclerosis Study. Am J Epidemiol 142:724-732
21. Hollenbeck CB, Chen N, Chen YDI, Reaven GM (1984) Relationship between the plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects. Diabetes 33:460-463
22. Saad MF, Anderson RL, Laws A et al. (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121
23. Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965
24. Rodriguez O, Collier E, Arakaki R, Gorden P (1992) Characterization of purified autoantibodies to the insulin receptor from six patients with type B insulin resistance. Metabolism 41:325-331
25. Flier JS, Kahn CR, Roth J, Bar RS (1975) Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63-65
26. Flier JS, Kahn CR, Jarrett DB, Roth J (1976) Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. J Clin Invest 58:1442-1449